Model
Edge
Ultragenyx Pharmaceutical Inc.
0001603347
Filing type
4
Filing date
Sep 18, 2025
Updated
Sep 19, 2025 ยท 4:23 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership